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PQ22a: Participant Information and Consent Form for Trial Participants in the Standard of Care Arm 
v1.0; 31st March 2016 
 
                
 
Title: Investigating interventions to increase uptake of HIV testing and linkage 
into care or prevention for male partners of pregnant women in antenatal 
clinics in urban Blantyre, Malawi: an adaptive Phase II multi-arm multi-stage 
cluster randomised trial 
 
Principal Investigator: Mr. Augustine Choko 
 




Hello. My name is ……………………………………………, and I am working with Malawi Liverpool Wellcome 
Trust (MLW) on behalf of Mr. Augustine Choko and colleagues. We are conducting a study to identify 
interventions for increasing uptake of HIV testing and linkage into care or prevention for male 
partners of pregnant women in antenatal care (ANC). We would like to find the most promising 
interventions, which could be further investigated in a larger study in order to address the problem 
of low uptake of HIV testing and linkage into care or prevention among male partners of pregnant 
women.  
 
Request for your Voluntary Participation 
I would like to ask you to voluntarily participate in this study. You have been identified 
because you are attending ANC services at a public primary healthcare facility in urban 
Blantyre for the first time. We consider that your participation would help us reach out to 
your partner but more importantly would help your partner by informing him about the 
services that we are offering. 
 
Procedure 
After the group information about the study, now I would like to give you some more 
information about the study and also ask you some questions related to you and your partner. 
The interview will not exceed 10 minutes and will include questions about your and your 
partner’s personal information and HIV testing. At the end of the interview I will give you a 
personalised invitation letter to give to your partner so that he can use the letter to come to 
our “male friendly clinic” alone or together with you.  At this clinic we are offering free HIV 
testing, facilitated HIV treatment initiation, a chance to be circumcised, and information 
about birth preparedness. As part of the study we will want to have a final interview with you 
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when you come back for your next ANC visit in four weeks’ time. The main aim of this follow-
up interview is to check if your bringing up this discussion with your partner led to any 
problems and whether or not your partner tested and linked to the “male friendly clinic”. 
 
Your participation is entirely voluntary. If you decide to take part, you may withdraw from the 
interviews or the study any time. You also have a right not to answer any particular question 
or questions that will be asked. Declining to participate in the study will not affect any health 




All personal information collected in this study will be kept strictly confidential. I will not share 
the information you provide with anyone who is not part of this research. But it may be shared 
with fellow researchers and may also be published through meetings or journals in a manner 
that does not reveal your identity. Before sharing in this manner, the information from you 
will be combined with that from other research participants. Information which could identify 
you or anyone related to you will never be released. This also means that names of study 
participants, including your own will not be included when sharing the data. Data collection 
equipment and the data collected will be kept with identifiers, locked, and only accessible to 
people that have authorised access. 
 
Risks 
You may be uncomfortable with some of the questions that I will ask. You are perfectly 
entitled to refuse to discuss issues that you do not want to. 
 
Benefits 
There are no direct benefits to you in your taking part in this study. However, what we learn 
from this study would help develop ways of successfully reaching out to male partners, offer 
them an HIV test and link them to appropriate follow-on services. It would thus help us inform 
health authorities in the Ministry of Health regarding which interventions truly hold potential 




You will not receive payment for participating in the study. You will however, be offered a 
small compensation for your time amounting to MWK1,000. 
 
Contact details 
This research has been approved by the College of Medicine Research Ethics Committee 
(COMREC) and the London School of Hygiene and Tropical Medicine Research Ethics 
Committee. If you have any questions regarding your rights as a research participant, or 
concerns on how you have been treated in the study, please feel free to contact Mr. 
Augustine Choko [+265 (0) 999 577 452] or [augutc@gmail.com]. If you have any questions 
regarding your rights as a research participant, or concerns  on how you have been treated in 
the study, please feel free to contact COMREC Secretariat, College of Medicine, Private Bag 
360, Chichiri, Blantyre 3 or call on  01871911 ext 334. 
 
Consent Declaration 
If you agree to voluntarily participate in the study, please sign or write your initial or your 
thumb print below to show that you understand the information above and that your consent 
is given voluntarily. 
 
1. I have received and read or had read to me the information sheet provided by the 
Researcher that explains in detail the reasons for the study. 
2. I have understood the purpose of the research. 
3. I have asked all the questions that I have about the purpose of the research and feel that 
I have enough information about it. 
4. I understand the reasons for this study. 
5. I am willing to take part in the study. 
6. I understand what I will be required to do if I participate in the study. 
7. I know that I have the right to leave the study at any time or to refuse to answer any 
questions. 
8. If I do not agree to take part in this study I understand that I will not be penalized for doing 
so by the researcher nor by any medical service providers in the future. 





------------------------------------------------   -------/--------/------- 




-------------------------------------------------  -------/--------/------- 
Signature of person obtaining consent   Date 
 
 
If the participant gave verbal consent, please enter the name of person who witnessed the 
consent here, and their signature: 
 
-------------------------------------------------      -----/-------/--------         ----------------------------------- 






PQ23a: Participant Information and Consent Form for Trial Participants in the Self-Test Kits only Arm 
v1.0; 31st March 2016 
 
 
                
 
Title: Investigating interventions to increase uptake of HIV testing and linkage 
into care or prevention for male partners of pregnant women in antenatal 
clinics in urban Blantyre, Malawi: an adaptive Phase II multi-arm multi-stage 
cluster randomised trial 
 
Principal Investigator: Mr. Augustine Choko 
 




Hello. My name is ……………………………………………, and I am working with Malawi Liverpool Wellcome 
Trust (MLW) on behalf of Mr. Augustine Choko and colleagues. We are conducting a study to identify 
interventions for increasing uptake of HIV testing and linkage into care or prevention for male 
partners of pregnant women in antenatal care (ANC). We would like to find the most promising 
interventions, which could be further investigated in a larger study in order to address the problem 
of low uptake of HIV testing and linkage into care or prevention among male partners of pregnant 
women.  
 
Request for your Voluntary Participation 
I would like to ask you to voluntarily participate in this study. You have been identified 
because you are attending ANC services at a public primary healthcare facility in urban 
Blantyre for the first time. We consider that your participation would help us reach out to 
your partner but more importantly would help your partner by informing him about the 
services that we are offering. 
 
Procedure 
After the group information about the study, now I would like to give you some more 
information about the study and also ask you some questions related to you and your partner. 
The interview will not exceed 10 minutes and will include questions about your and your 
partner’s personal information and HIV testing. At the end of the interview I will give you a 
personalised invitation letter to give to your partner so that he can use the letter to come to 
our “male friendly clinic” alone or together with you. I will also give you two self-test kits to 
take home to allow your partner to self-test alone or together with you. At this clinic we are 
offering free confirmatory HIV testing for people who report a positive HIV test followed by 
Malawi-Liverpool-Wellcome Trust  
Clinical Research Programme 
P.O Box 30096, Chichiri, Blantyre 3, 
Malawi. 
Tel. +265 1 876444  Fax +265 1 875774 
facilitated HIV treatment initiation, a chance to be circumcised if HIV negative, and 
information about birth preparedness.  
 
As part of the study we will want to have a final interview with you when you come back for 
your next ANC visit in four weeks’ time. The main aim of this follow-up interview is to check 
if your bringing up this discussion with your partner led to any problems and whether or not 
your partner tested and linked to the “male friendly clinic”. We will also ask you to bring back 




Your participation is entirely voluntary. If you decide to take part, you may withdraw from the 
interviews or the study any time. You also have a right not to answer any particular question 
or questions that will be asked. Declining to participate in the study will not affect any health 




All personal information collected in this study will be kept strictly confidential. I will not share 
the information you provide with anyone who is not part of this research. But it may be shared 
with fellow researchers and may also be published through meetings or journals in a manner 
that does not reveal your identity. Before sharing in this manner, the information from you 
will be combined with that from other research participants. Information which could identify 
you or anyone related to you will never be released. This also means that names of study 
participants, including your own will not be included when sharing the data. Data collection 
equipment and the data collected will be kept with identifiers, locked, and only accessible to 
people that have authorised access. 
 
Risks 
You may be uncomfortable with some of the questions that I will ask. You are perfectly 
entitled to refuse to discuss issues that you do not want to. The oral HIV self-test kit is safe to 
use and is approved for use by the Federal Drug Administration. 
 
Benefits 
There are no direct benefits to you in your taking part in this study. However, what we learn 
from this study would help develop ways of successfully reaching out to male partners, offer 
them an HIV test and link them to appropriate follow-on services. It would thus help us inform 
health authorities in the Ministry of Health regarding which interventions truly hold potential 




You will not receive payment for participating in the study. You will however, be offered a 
small compensation for your time amounting to MWK1,000. 
 
Contact details 
This research has been approved by the College of Medicine Research Ethics Committee 
(COMREC) and the London School of Hygiene and Tropical Medicine Research Ethics 
Committee. If you have any questions regarding your rights as a research participant, or 
concerns on how you have been treated in the study, please feel free to contact Mr. 
Augustine Choko [+265 (0) 999 577 452] or [augutc@gmail.com]. If you have any questions 
regarding your rights as a research participant, or concerns  on how you have been treated in 
the study, please feel free to contact COMREC Secretariat, College of Medicine, Private Bag 




If you agree to voluntarily participate in the study, please sign or write your initial or your 
thumb print below to show that you understand the information above and that your consent 
is given voluntarily. 
 
1. I have received and read or had read to me the information sheet provided by the 
Researcher that explains in detail the reasons for the study. 
2. I have understood the purpose of the research. 
3. I have asked all the questions that I have about the purpose of the research and feel that 
I have enough information about it. 
4. I understand the reasons for this study. 
5. I am willing to take part in the study. 
6. I understand what I will be required to do if I participate in the study. 
7. I know that I have the right to leave the study at any time or to refuse to answer any 
questions. 
8. If I do not agree to take part in this study I understand that I will not be penalized for doing 
so by the researcher nor by any medical service providers in the future. 





------------------------------------------------   -------/--------/------- 




-------------------------------------------------  -------/--------/------- 
Signature of person obtaining consent   Date 
 
 
If the participant gave verbal consent, please enter the name of person who witnessed the 
consent here, and their signature: 
 
-------------------------------------------------      -----/-------/--------         ----------------------------------- 
Name of Witness (BLOCK CAPITALS)              Date                         Signature or thumb print 
 
  
PQ24a: Participant Information and Consent Form for Trial Participants in the Self-Test Kits + a Low 
Financial Incentive Arm v1.0; 31st March 2016 
 
 
                
 
Title: Investigating interventions to increase uptake of HIV testing and linkage 
into care or prevention for male partners of pregnant women in antenatal 
clinics in urban Blantyre, Malawi: an adaptive Phase II multi-arm multi-stage 
cluster randomised trial 
 
Principal Investigator: Mr. Augustine Choko 
 




Hello. My name is ……………………………………………, and I am working with Malawi Liverpool Wellcome 
Trust (MLW) on behalf of Mr. Augustine Choko and colleagues. We are conducting a study to identify 
interventions for increasing uptake of HIV testing and linkage into care or prevention for male 
partners of pregnant women in antenatal care (ANC). We would like to find the most promising 
interventions, which could be further investigated in a larger study in order to address the problem 
of low uptake of HIV testing and linkage into care or prevention among male partners of pregnant 
women.  
 
Request for your Voluntary Participation 
I would like to ask you to voluntarily participate in this study. You have been identified 
because you are attending ANC services at a public primary healthcare facility in urban 
Blantyre for the first time. We consider that your participation would help us reach out to 
your partner but more importantly would help your partner by informing him about the 
services that we are offering. 
 
Procedure 
After the group information about the study, now I would like to give you some more 
information about the study and also ask you some questions related to you and your partner. 
The interview will not exceed 10 minutes and will include questions about your and your 
partner’s personal information and HIV testing. At the end of the interview I will give you a 
personalised invitation letter to give to your partner so that he can use the letter to come to 
our “male friendly clinic” alone or together with you. I will also give you two self-test kits to 
take home to allow your partner to self-test alone or together with you. At this clinic we are 
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offering free confirmatory HIV testing for people who report a positive HIV test followed by 
facilitated HIV treatment initiation, a chance to be circumcised if HIV negative, and 
information about birth preparedness. Your partner will get MWK2,000 as a transport 
reimbursement through Airtel money after getting the services that we are offering at the 
male friendly clinic.  
 
As part of the study we will want to have a final interview with you when you come back for 
your next ANC visit in four weeks’ time. The main aim of this follow-up interview is to check 
if your bringing up this discussion with your partner led to any problems and whether or not 
your partner tested and linked to the “male friendly clinic”. We will also ask you to bring back 
used or unused self-test kits at your next visit so that we can reconcile our stock with our main 
office. 
 
Your participation is entirely voluntary. If you decide to take part, you may withdraw from the 
interviews or the study any time. You also have a right not to answer any particular question 
or questions that will be asked. Declining to participate in the study will not affect any health 




All personal information collected in this study will be kept strictly confidential. I will not share 
the information you provide with anyone who is not part of this research. But it may be shared 
with fellow researchers and may also be published through meetings or journals in a manner 
that does not reveal your identity. Before sharing in this manner, the information from you 
will be combined with that from other research participants. Information which could identify 
you or anyone related to you will never be released. This also means that names of study 
participants, including your own will not be included when sharing the data. Data collection 
equipment and the data collected will be kept with identifiers, locked, and only accessible to 
people that have authorised access. 
 
Risks 
You may be uncomfortable with some of the questions that I will ask. You are perfectly 
entitled to refuse to discuss issues that you do not want to. The oral HIV self-test kit is safe to 
use and is approved for use by the Federal Drug Administration. 
 
Benefits 
There are no direct benefits to you in your taking part in this study. However, what we learn 
from this study would help develop ways of successfully reaching out to male partners, offer 
them an HIV test and link them to appropriate follow-on services. It would thus help us inform 
health authorities in the Ministry of Health regarding which interventions truly hold potential 




You will not receive payment for participating in the study. You will however, be offered a 
small compensation for your time amounting to MWK1,000. 
 
Contact details 
This research has been approved by the College of Medicine Research Ethics Committee 
(COMREC) and the London School of Hygiene and Tropical Medicine Research Ethics 
Committee. If you have any questions regarding your rights as a research participant, or 
concerns on how you have been treated in the study, please feel free to contact Mr. 
Augustine Choko [+265 (0) 999 577 452] or [augutc@gmail.com]. If you have any questions 
regarding your rights as a research participant, or concerns  on how you have been treated in 
the study, please feel free to contact COMREC Secretariat, College of Medicine, Private Bag 




If you agree to voluntarily participate in the study, please sign or write your initial or your 
thumb print below to show that you understand the information above and that your consent 
is given voluntarily. 
 
1. I have received and read or had read to me the information sheet provided by the 
Researcher that explains in detail the reasons for the study. 
2. I have understood the purpose of the research. 
3. I have asked all the questions that I have about the purpose of the research and feel that 
I have enough information about it. 
4. I understand the reasons for this study. 
5. I am willing to take part in the study. 
6. I understand what I will be required to do if I participate in the study. 
7. I know that I have the right to leave the study at any time or to refuse to answer any 
questions. 
8. If I do not agree to take part in this study I understand that I will not be penalized for doing 
so by the researcher nor by any medical service providers in the future. 





------------------------------------------------   -------/--------/------- 




-------------------------------------------------  -------/--------/------- 
Signature of person obtaining consent   Date 
 
 
If the participant gave verbal consent, please enter the name of person who witnessed the 
consent here, and their signature: 
 
-------------------------------------------------      -----/-------/--------         ----------------------------------- 
Name of Witness (BLOCK CAPITALS)              Date                         Signature or thumb print 
 
  
PQ25a: Participant Information and Consent Form for Trial Participants in the Self-Test Kits + a High 




                
 
Title: Investigating interventions to increase uptake of HIV testing and linkage 
into care or prevention for male partners of pregnant women in antenatal 
clinics in urban Blantyre, Malawi: an adaptive Phase II multi-arm multi-stage 
cluster randomised trial 
 
Principal Investigator: Mr. Augustine Choko 
 




Hello. My name is ……………………………………………, and I am working with Malawi Liverpool Wellcome 
Trust (MLW) on behalf of Mr. Augustine Choko and colleagues. We are conducting a study to identify 
interventions for increasing uptake of HIV testing and linkage into care or prevention for male 
partners of pregnant women in antenatal care (ANC). We would like to find the most promising 
interventions, which could be further investigated in a larger study in order to address the problem 
of low uptake of HIV testing and linkage into care or prevention among male partners of pregnant 
women.  
 
Request for your Voluntary Participation 
I would like to ask you to voluntarily participate in this study. You have been identified 
because you are attending ANC services at a public primary healthcare facility in urban 
Blantyre for the first time. We consider that your participation would help us reach out to 
your partner but more importantly would help your partner by informing him about the 
services that we are offering. 
 
Procedure 
After the group information about the study, now I would like to give you some more 
information about the study and also ask you some questions related to you and your partner. 
The interview will not exceed 10 minutes and will include questions about your and your 
partner’s personal information and HIV testing. At the end of the interview I will give you a 
personalised invitation letter to give to your partner so that he can use the letter to come to 
our “male friendly clinic” alone or together with you. I will also give you two self-test kits to 
take home to allow your partner to self-test alone or together with you. At this clinic we are 
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offering free confirmatory HIV testing for people who report a positive HIV test followed by 
facilitated HIV treatment initiation, a chance to be circumcised if HIV negative, and 
information about birth preparedness. Your partner will get MWK6,500 as a transport 
reimbursement and compensation for lost time through Airtel money after getting the 
services that we are offering at the male friendly clinic.  
 
As part of the study we will want to have a final interview with you when you come back for 
your next ANC visit in four weeks’ time. The main aim of this follow-up interview is to check 
if your bringing up this discussion with your partner led to any problems and whether or not 
your partner tested and linked to the “male friendly clinic”. We will also ask you to bring back 




Your participation is entirely voluntary. If you decide to take part, you may withdraw from the 
interviews or the study any time. You also have a right not to answer any particular question 
or questions that will be asked. Declining to participate in the study will not affect any health 




All personal information collected in this study will be kept strictly confidential. I will not share 
the information you provide with anyone who is not part of this research. But it may be shared 
with fellow researchers and may also be published through meetings or journals in a manner 
that does not reveal your identity. Before sharing in this manner, the information from you 
will be combined with that from other research participants. Information which could identify 
you or anyone related to you will never be released. This also means that names of study 
participants, including your own will not be included when sharing the data. Data collection 
equipment and the data collected will be kept with identifiers, locked, and only accessible to 
people that have authorised access. 
 
Risks 
You may be uncomfortable with some of the questions that I will ask. You are perfectly 
entitled to refuse to discuss issues that you do not want to. 
 
Benefits 
There are no direct benefits to you in your taking part in this study. However, what we learn 
from this study would help develop ways of successfully reaching out to male partners, offer 
them an HIV test and link them to appropriate follow-on services. It would thus help us inform 
health authorities in the Ministry of Health regarding which interventions truly hold potential 




You will not receive payment for participating in the study. You will however, be offered a 
small compensation for your time amounting to MWK1,000. 
 
Contact details 
This research has been approved by the College of Medicine Research Ethics Committee 
(COMREC) and the London School of Hygiene and Tropical Medicine Research Ethics 
Committee. If you have any questions regarding your rights as a research participant, or 
concerns on how you have been treated in the study, please feel free to contact Mr. 
Augustine Choko [+265 (0) 999 577 452] or [augutc@gmail.com]. If you have any questions 
regarding your rights as a research participant, or concerns  on how you have been treated in 
the study, please feel free to contact COMREC Secretariat, College of Medicine, Private Bag 




If you agree to voluntarily participate in the study, please sign or write your initial or your 
thumb print below to show that you understand the information above and that your consent 
is given voluntarily. 
 
1. I have received and read or had read to me the information sheet provided by the 
Researcher that explains in detail the reasons for the study. 
2. I have understood the purpose of the research. 
3. I have asked all the questions that I have about the purpose of the research and feel that 
I have enough information about it. 
4. I understand the reasons for this study. 
5. I am willing to take part in the study. 
6. I understand what I will be required to do if I participate in the study. 
7. I know that I have the right to leave the study at any time or to refuse to answer any 
questions. 
8. If I do not agree to take part in this study I understand that I will not be penalized for doing 
so by the researcher nor by any medical service providers in the future. 





------------------------------------------------   -------/--------/------- 




-------------------------------------------------  -------/--------/------- 
Signature of person obtaining consent   Date 
 
 
If the participant gave verbal consent, please enter the name of person who witnessed the 
consent here, and their signature: 
 
-------------------------------------------------      -----/-------/--------         ----------------------------------- 
Name of Witness (BLOCK CAPITALS)              Date                         Signature or thumb print 
 
  
PQ26a: Participant Information and Consent Form for Trial Participants in the Self-Test Kits + a 
Lottery Financial Incentive Arm v1.0; 31st March 2016 
 
 
                
 
Title: Investigating interventions to increase uptake of HIV testing and linkage 
into care or prevention for male partners of pregnant women in antenatal 
clinics in urban Blantyre, Malawi: an adaptive Phase II multi-arm multi-stage 
cluster randomised trial 
 
Principal Investigator: Mr. Augustine Choko 
 




Hello. My name is ……………………………………………, and I am working with Malawi Liverpool Wellcome 
Trust (MLW) on behalf of Mr. Augustine Choko and colleagues. We are conducting a study to identify 
interventions for increasing uptake of HIV testing and linkage into care or prevention for male 
partners of pregnant women in antenatal care (ANC). We would like to find the most promising 
interventions, which could be further investigated in a larger study in order to address the problem 
of low uptake of HIV testing and linkage into care or prevention among male partners of pregnant 
women.  
Request for your Voluntary Participation 
I would like to ask you to voluntarily participate in this study. You have been identified 
because you are attending ANC services at a public primary healthcare facility in urban 
Blantyre for the first time. We consider that your participation would help us reach out to 
your partner but more importantly would help your partner by informing him about the 
services that we are offering. 
Procedure 
After the group information about the study, now I would like to give you some more 
information about the study and also ask you some questions related to you and your partner. 
The interview will not exceed 10 minutes and will include questions about your and your 
partner’s personal information and HIV testing. At the end of the interview I will give you a 
personalised invitation letter to give to your partner so that he can use the letter to come to 
our “male friendly clinic” alone or together with you. I will also give you two self-test kits to 
take home to allow your partner to self-test alone or together with you. At this clinic we are 
offering free confirmatory HIV testing for people who report a positive HIV test followed by 
facilitated HIV treatment initiation, a chance to be circumcised if HIV negative, and 
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information about birth preparedness. Your partner will have a 10% chance of winning 
MWK19,500 which will be given through Airtel money after getting the services that we are 
offering at the male friendly clinic.  
 
As part of the study we will want to have a final interview with you when you come back for 
your next ANC visit in four weeks’ time. The main aim of this follow-up interview is to check 
if your bringing up this discussion with your partner led to any problems and whether or not 
your partner tested and linked to the “male friendly clinic”. We will also ask you to bring back 
used or unused self-test kits at your next visit so that we can reconcile our stock with our main 
office. 
 
Your participation is entirely voluntary. If you decide to take part, you may withdraw from the 
interviews or the study any time. You also have a right not to answer any particular question 
or questions that will be asked. Declining to participate in the study will not affect any health 
services that you or any person related to you may be currently receiving or may require in 
future.  
Confidentiality 
All personal information collected in this study will be kept strictly confidential. I will not share 
the information you provide with anyone who is not part of this research. But it may be shared 
with fellow researchers and may also be published through meetings or journals in a manner 
that does not reveal your identity. Before sharing in this manner, the information from you 
will be combined with that from other research participants. Information which could identify 
you or anyone related to you will never be released. This also means that names of study 
participants, including your own will not be included when sharing the data. Data collection 
equipment and the data collected will be kept with identifiers, locked, and only accessible to 
people that have authorised access. 
Risks 
You may be uncomfortable with some of the questions that I will ask. You are perfectly 
entitled to refuse to discuss issues that you do not want to. 
Benefits 
There are no direct benefits to you in your taking part in this study. However, what we learn 
from this study would help develop ways of successfully reaching out to male partners, offer 
them an HIV test and link them to appropriate follow-on services. It would thus help us inform 
health authorities in the Ministry of Health regarding which interventions truly hold potential 
to reduce the problem of low uptake of testing and linkage among male partners of pregnant 
women. 
Compensation 
You will not receive payment for participating in the study. You will however, be offered a 
small compensation for your time amounting to MWK1,000. 
Contact details 
This research has been approved by the College of Medicine Research Ethics Committee 
(COMREC) and the London School of Hygiene and Tropical Medicine Research Ethics 
Committee. If you have any questions regarding your rights as a research participant, or 
concerns on how you have been treated in the study, please feel free to contact Mr. 
Augustine Choko [+265 (0) 999 577 452] or [augutc@gmail.com]. If you have any questions 
regarding your rights as a research participant, or concerns  on how you have been treated in 
the study, please feel free to contact COMREC Secretariat, College of Medicine, Private Bag 




If you agree to voluntarily participate in the study, please sign or write your initial or your 
thumb print below to show that you understand the information above and that your consent 
is given voluntarily. 
 
1. I have received and read or had read to me the information sheet provided by the 
Researcher that explains in detail the reasons for the study. 
2. I have understood the purpose of the research. 
3. I have asked all the questions that I have about the purpose of the research and feel that 
I have enough information about it. 
4. I understand the reasons for this study. 
5. I am willing to take part in the study. 
6. I understand what I will be required to do if I participate in the study. 
7. I know that I have the right to leave the study at any time or to refuse to answer any 
questions. 
8. If I do not agree to take part in this study I understand that I will not be penalized for doing 
so by the researcher nor by any medical service providers in the future. 





------------------------------------------------   -------/--------/------- 




-------------------------------------------------  -------/--------/------- 
Signature of person obtaining consent   Date 
 
 
If the participant gave verbal consent, please enter the name of person who witnessed the 
consent here, and their signature: 
 
-------------------------------------------------      -----/-------/--------         ----------------------------------- 
Name of Witness (BLOCK CAPITALS)              Date                         Signature or thumb print 
 
  
PQ27a: Participant Information and Consent Form for Trial Participants in the Self-Test Kits + a 
Phone Reminder Arm v1.0; 31st March 2016 
 
 
                
 
Title: Investigating interventions to increase uptake of HIV testing and linkage 
into care or prevention for male partners of pregnant women in antenatal 
clinics in urban Blantyre, Malawi: an adaptive Phase II multi-arm multi-stage 
cluster randomised trial 
 
Principal Investigator: Mr. Augustine Choko 
 




Hello. My name is ……………………………………………, and I am working with Malawi Liverpool Wellcome 
Trust (MLW) on behalf of Mr. Augustine Choko and colleagues. We are conducting a study to identify 
interventions for increasing uptake of HIV testing and linkage into care or prevention for male 
partners of pregnant women in antenatal care (ANC). We would like to find the most promising 
interventions, which could be further investigated in a larger study in order to address the problem 
of low uptake of HIV testing and linkage into care or prevention among male partners of pregnant 
women.  
Request for your Voluntary Participation 
I would like to ask you to voluntarily participate in this study. You have been identified 
because you are attending ANC services at a public primary healthcare facility in urban 
Blantyre for the first time. We consider that your participation would help us reach out to 
your partner but more importantly would help your partner by informing him about the 
services that we are offering. 
Procedure 
After the group information about the study, now I would like to give you some more 
information about the study and also ask you some questions related to you and your partner. 
The interview will not exceed 10 minutes and will include questions about your and your 
partner’s personal information and HIV testing. At the end of the interview I will give you a 
personalised invitation letter to give to your partner so that he can use the letter to come to 
our “male friendly clinic” alone or together with you. I will also give you two self-test kits to 
take home to allow your partner to self-test alone or together with you. At this clinic we are 
offering free confirmatory HIV testing for people who report a positive HIV test followed by 
facilitated HIV treatment initiation, a chance to be circumcised if HIV negative, and 
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information about birth preparedness. We will call your partner tomorrow and after five days 
to remind him to self-test and come to the male friendly clinic.  
 
As part of the study we will want to have a final interview with you when you come back for 
your next ANC visit in four weeks’ time. The main aim of this follow-up interview is to check 
if your bringing up this discussion with your partner led to any problems and whether or not 
your partner tested and linked to the “male friendly clinic”. We will also ask you to bring back 
used or unused self-test kits at your next visit so that we can reconcile our stock with our main 
office. 
 
Your participation is entirely voluntary. If you decide to take part, you may withdraw from the 
interviews or the study any time. You also have a right not to answer any particular question 
or questions that will be asked. Declining to participate in the study will not affect any health 
services that you or any person related to you may be currently receiving or may require in 
future.  
Confidentiality 
All personal information collected in this study will be kept strictly confidential. I will not share 
the information you provide with anyone who is not part of this research. But it may be shared 
with fellow researchers and may also be published through meetings or journals in a manner 
that does not reveal your identity. Before sharing in this manner, the information from you 
will be combined with that from other research participants. Information which could identify 
you or anyone related to you will never be released. This also means that names of study 
participants, including your own will not be included when sharing the data. Data collection 
equipment and the data collected will be kept with identifiers, locked, and only accessible to 
people that have authorised access. 
Risks 
You may be uncomfortable with some of the questions that I will ask. You are perfectly 
entitled to refuse to discuss issues that you do not want to. 
Benefits 
There are no direct benefits to you in your taking part in this study. However, what we learn 
from this study would help develop ways of successfully reaching out to male partners, offer 
them an HIV test and link them to appropriate follow-on services. It would thus help us inform 
health authorities in the Ministry of Health regarding which interventions truly hold potential 
to reduce the problem of low uptake of testing and linkage among male partners of pregnant 
women. 
Compensation 
You will not receive payment for participating in the study. You will however, be offered a 
small compensation for your time amounting to MWK1,000. 
Contact details 
This research has been approved by the College of Medicine Research Ethics Committee 
(COMREC) and the London School of Hygiene and Tropical Medicine Research Ethics 
Committee. If you have any questions regarding your rights as a research participant, or 
concerns on how you have been treated in the study, please feel free to contact Mr. 
Augustine Choko [+265 (0) 999 577 452] or [augutc@gmail.com]. If you have any questions 
regarding your rights as a research participant, or concerns  on how you have been treated in 
the study, please feel free to contact COMREC Secretariat, College of Medicine, Private Bag 
360, Chichiri, Blantyre 3 or call on   01871911 ext 334. 
Consent Declaration 
If you agree to voluntarily participate in the study, please sign or write your initial or your 
thumb print below to show that you understand the information above and that your consent 
is given voluntarily. 
 
1. I have received and read or had read to me the information sheet provided by the 
Researcher that explains in detail the reasons for the study. 
2. I have understood the purpose of the research. 
3. I have asked all the questions that I have about the purpose of the research and feel that 
I have enough information about it. 
4. I understand the reasons for this study. 
5. I am willing to take part in the study. 
6. I understand what I will be required to do if I participate in the study. 
7. I know that I have the right to leave the study at any time or to refuse to answer any 
questions. 
8. If I do not agree to take part in this study I understand that I will not be penalized for doing 
so by the researcher nor by any medical service providers in the future. 





------------------------------------------------   -------/--------/------- 




-------------------------------------------------  -------/--------/------- 
Signature of person obtaining consent   Date 
 
 
If the participant gave verbal consent, please enter the name of person who witnessed the 
consent here, and their signature: 
 
-------------------------------------------------      -----/-------/--------         ----------------------------------- 
Name of Witness (BLOCK CAPITALS)              Date                         Signature or thumb print 
